US Cancer Centers of Excellence Strategies for Increased Inclusion of Racial and Ethnic Minorities in Clinical Trials.

JM, Regnante; NA, Richie; L, Fashoyin-Aje; M, Vichnin; M, Ford; UB, Roy; K, Turner; LL, Hall; E, Gonzalez; N, Esnaola; LT, Clark; HC 3rd, Adams; OB, Alese; K, Gogineni; L, McNeill; D, Petereit; I, Sargeant; J, Dang; C, Obasaju; Q, Highsmith; SC, Lee; SC, Hoover; EL, Williams; MS Jr, Chen

doi:10.1200/jop.18.00638

Public

US Cancer Centers of Excellence Strategies for Increased Inclusion of Racial and Ethnic Minorities in Clinical Trials.

Shared by NobleBlocks on Mar 4, 2019 • 12:00 AM UTC

Authors:

Regnante JM

Richie NA

Fashoyin-Aje L

Abstract

<h4>Purpose</h4>Participation of racial and ethnic minority groups (REMGs) in cancer trials is disproportionately low despite a high prevalence of certain cancers in REMG populations. We aimed to identify notable practices used by leading US cancer centers that facilitate REMG participation in cance...

Discussions